BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20710099)

  • 1. An overview of cancer of the prostate diagnosis and management in Nigeria: the experience in a Nigerian tertiary hospital.
    Ajape AA; Ibrahim KO; Fakeye JA; Abiola OO
    Ann Afr Med; 2010; 9(3):113-7. PubMed ID: 20710099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer in Maiduguri.
    Yawe KT; Tahir MB; Nggada HA
    West Afr J Med; 2006; 25(4):298-300. PubMed ID: 17402521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of prostate cancer with needle biopsy: should all cases be biopsied before treatment?
    Oranusi CK; Ugezu AI; Nwofor A
    Niger J Clin Pract; 2012; 15(1):48-50. PubMed ID: 22437089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of prostate cancer in southwestern Nigeria.
    Badmus TA; Adesunkanmi AR; Yusuf BM; Oseni GO; Eziyi AK; Bakare TI; Adetiloye JA; Badmus SA
    Urology; 2010 Aug; 76(2):412-6. PubMed ID: 20451979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK.
    Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW
    BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter study on the detection of prostate cancer by digital rectal examination and prostate-specific antigen in men with or without urinary symptoms. Cooperative Group for Diagnosis of Prostate Cancer.
    Eur Urol; 1997; 32(2):133-9. PubMed ID: 9286642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active surveillance for the management of prostate cancer in a contemporary cohort.
    Dall'Era MA; Konety BR; Cowan JE; Shinohara K; Stauf F; Cooperberg MR; Meng MV; Kane CJ; Perez N; Master VA; Carroll PR
    Cancer; 2008 Jun; 112(12):2664-70. PubMed ID: 18433013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are doctors examining prostates in university hospital?
    Lim CH; Quinlan DM
    Urology; 2007 Nov; 70(5):843-5. PubMed ID: 18068436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer: pattern and outcome of management in University of Ilorin Teaching Hospital, Ilorin, Nigeria.
    Rahman GA
    Ann Afr Med; 2010; 9(3):164-9. PubMed ID: 20710108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
    J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma].
    Recker F
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1881-90. PubMed ID: 8984601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
    Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
    Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of prostate cancer in China: a multicenter report of 6 institutions.
    Peyromaure M; Debré B; Mao K; Zhang G; Wang Y; Sun Z; Xu D; Jiang J; Sun Y
    J Urol; 2005 Nov; 174(5):1794-7. PubMed ID: 16217289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer].
    Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V
    Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.